Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aldosterone, (+-)-isomer
2. Aldosterone, (11 Beta,17 Alpha)-isomer
1. 52-39-1
2. Electrocortin
3. Aldocortin
4. Aldocorten
5. Aldocortene
6. (+)-aldosterone
7. Reichstein X
8. Elektrocortin
9. D-aldosterone
10. 18-oxocorticosterone
11. Aldosteronum
12. [3h]aldosterone
13. 11beta,21-dihydroxypregn-4-ene-3,18,20-trione
14. 11beta,21-dihydroxy-3,20-diketo-4-pregnen-18-al
15. 11beta,21-dihydroxy-3,20-diketopregn-4-ene-18-al
16. 18-formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione
17. Pregn-4-en-18-al, 11,21-dihydroxy-3,20-dioxo-, (11b)-
18. (11beta)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al
19. Nsc 73856
20. 11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al
21. Nsc-73856
22. (8s,9s,10r,11s,13r,14s,17s)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-13-carbaldehyde
23. 11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al, 18,11-halbacetal
24. 11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al
25. 11beta,21-dihydroxy-3,20-dioxo-pregn-4-ene-18-al
26. Chebi:27584
27. 4964p6t9rb
28. Aldosterone (inn)
29. 11.beta.,21-dihydroxypregn-4-ene-3,18,20-trione
30. Pregn-4-en-18-al, 11,21-dihydroxy-3,20-dioxo-, (11beta)-
31. Aldosteronum [inn-latin]
32. Aldosterona
33. Aldosterona [inn-spanish]
34. 18-aldocorticosterone
35. Aldosterone [inn]
36. Aldosterone [inn:ban:dcf]
37. [3h]-aldosterone
38. Smr000857170
39. Einecs 200-139-9
40. Brn 3224996
41. Unii-4964p6t9rb
42. Delta-aldosterone
43. Aldosterone Solution
44. 18-ketocorticosterone
45. 11,21-dihydroxy-3,20-dioxopregn-4-en-18-al
46. Aldosterone [mi]
47. Schembl1675
48. Aldosterone [mart.]
49. Aldosterone [who-dd]
50. 11b,21-dihydroxy-3,20-dioxo-pregn-4-en-18-al
51. 4-08-00-03491 (beilstein Handbook Reference)
52. Mls001333163
53. Mls001333164
54. Bidd:er0511
55. Chembl273453
56. Gtpl2872
57. Gtpl3452
58. Dtxsid7022419
59. Aldosterone, >=95% (hplc)
60. Bdbm19214
61. (11beta)-11,21-dihydroxy-3,20-dioxo-pregn-4-en-18-al
62. Hms2233d14
63. Nsc73856
64. Zinc3833824
65. Lmst02030026
66. Akos024462706
67. Db04630
68. Ncgc00164236-01
69. As-69489
70. Aldosterone 100 Microg/ml In Acetonitrile
71. Hy-113313
72. Cs-0059576
73. C01780
74. D10528
75. Q184564
76. Sr-01000838883
77. Sr-01000838883-2
78. 11beta,21-dihydroxy-3,20-dioxo-pregn-4-en-18-al
79. (11b)-11,21-dihydroxy-3,20-dioxo-pregn-4-en-18-al
80. Pregn-4-en-18-al,21-dihydroxy-3,20-dioxo-, (11.beta.)-
81. Pregn-4-ene-3,20-dione, 11beta,18-epoxy-18,21-dihydroxy-
82. (11alpha,14beta,17alpha)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al
83. (1s,2r,10s,11s,14s,15r,17s)-17-hydroxy-14-(2-hydroxyacetyl)-2-methyl-5-oxotetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-ene-15-carbaldehyde
84. 11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-13-carbaldehyde
85. Aldosterone Solution, 100 Mug/ml In Acetonitrile, Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 360.4 g/mol |
---|---|
Molecular Formula | C21H28O5 |
XLogP3 | 1.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 3 |
Exact Mass | 360.19367399 g/mol |
Monoisotopic Mass | 360.19367399 g/mol |
Topological Polar Surface Area | 91.7 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 682 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
At the late distal tubule and collecting duct, aldosterone has two main actions: 1) aldosterone acts on mineralocorticoid receptors (MR) on principal cells in the distal tubule of the kidney nephron, increasing the permeability of their apical (luminal) membrane to potassium and sodium and activates their basolateral Na+/K+ pumps, stimulating ATP hydrolysis leading to phosphorylation of the pump and a conformational change in the pump exposes the Na+ ions to the outside. The phosphorylated form of the pump has a low affinity for Na+ ions, hence reabsorbing sodium (Na+) ions and water into the blood, and secreting potassium (K+) ions into the urine; 2) aldosterone stimulates H+ secretion by intercalated cells in the collecting duct, regulating plasma bicarbonate (HCO3) levels and its acid/base balance; and 3) aldosterone may act on the central nervous system via the posterior pituitary gland to release vasopressin (ADH) which serves to conserve water by direct actions on renal tubular resorption.
H - Systemic hormonal preparations, excl. sex hormones and insulins
H02 - Corticosteroids for systemic use
H02A - Corticosteroids for systemic use, plain
H02AA - Mineralocorticoids
H02AA01 - Aldosterone
Market Place
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?